Hieff™ RNAiBoost in vitro transfection reagent relies on an exclusive delivery platform to efficiently and precisely deliver siRNA into cells, achieving >90% target gene silencing even in hard-to-transfect systems such as primary cells, with operation completed in 5 minutes, specifically designed for knockdown in primary and other hard-to-transfect cell lines, compatible with serum and antibiotics, and no medium change required post-transfectionWrite information about product introduction. Features Higher transfection efficiency: Achieves >90% target gene knockdown even in hard-to-transfect primary cells Lower siRNA requirement: Delivers high knockdown efficiency with siRNA concentrations as low...
Hieff™ RNAiBoost in vitro transfection reagent relies on an exclusive delivery platform to efficiently and precisely deliver siRNA into cells, achieving >90% target gene silencing even in hard-to-transfect systems such as primary cells, with operation completed in 5 minutes, specifically designed for knockdown in primary and other hard-to-transfect cell lines, compatible with serum and antibiotics, and no medium change required post-transfectionWrite information about product introduction.
Features
Higher transfection efficiency: Achieves >90% target gene knockdown even in hard-to-transfect primary cells
Lower siRNA requirement: Delivers high knockdown efficiency with siRNA concentrations as low as 2–50 nM
Simplified workflow: Complex formation in just 5 minutes; fully compatible with serum and antibiotics—no media change required
Components
|
Components No. |
Name |
40807ES01 |
40807ES03 |
40807ES04 |
|
40807-A |
RNAiBoost Transfection Reagent |
100 μL |
0.75 mL |
1.5 mL |
|
40807-B |
Enhancer |
300 μL |
3 × 0.75 mL |
3 × 1.5 mL |
Figures
High Knockdown Efficiency

Figure 1. siRNA transfection across different cells using Booster DNA&RNA Transfection Reagent versus supplier T*. The result demonstrates superior siRNA transfection efficiency of Booster.

Figure 2: Hard-to-Transfect Cell Lines-STC-1

Figure 3: Hard-to-Transfect Cell Lines-HepG2

Figure 4: Hard-to-Transfect Cell Lines-HK-2
Customer Cases
Primary Cell Transfection Cases
|
Cell Type |
Abbreviation |
Nucleic Acid Type |
|
BMDM |
siRNA((6-Well Plate) |
|
|
HUVEC |
siRNA |
|
|
BMDM |
siRNA(12-Well Plate) |
Tumor Cell Transfection Cases
|
Cell Type |
Abbreviation |
Nucleic Acid Type |
|
CEMT-4 |
siRNA |
|
|
HePG2 |
siRNA |
|
|
MCF-7 |
siRNA |
|
|
THP-1 |
siRNA |
|
|
Human monocytic leukemia cell(and-induced-to-MO-Macrophages) |
THP-1 |
siRNA |
|
THP-1 |
siRNA |
|
|
LLC |
siRNA |
|
|
U937 |
siRNA |
Tissue Cell Transfection Cases
|
Cell Type |
Abbreviation |
Nucleic Acid Type |
|
BEAS-2B |
siRNA |
|
|
HK-2 |
siRNA |
|
|
H9c2 |
siRNA |
|
|
HEK293 |
siRNA |
|
|
LX2 |
siRNA |
|
|
MCF |
siRNA |
|
|
NIH-3T3 |
siRNA |
|
|
RAW264.7 |
siRNA(6-Well Plate) |
|
|
RAW264.7 |
siRNA(24-Well Plate) |
|
|
RBE |
siRNA |
|
|
STC1 |
siRNA |
Try it for free!
Get a free sample of RNAiBoost and validate its performance in your own lab.
👉 [Request Sample Now]. Worldwide Shipping!
Learn More
Next-Gen siRNA Transfection | Achieve 90% Gene Knockdown with Ease
DNA Transfection?
The novel reagent here.
Storage
FAQ
40807ES is a lipid nanoparticle-based transfection reagent.
Citations
Documents
Applications
Potrebbe piacerti anche
Indagine
FAQ
Il prodotto è solo per scopi di ricerca e non è destinato all'uso terapeutico o diagnostico su esseri umani o animali. Prodotti e contenuti sono protetti da brevetti, marchi e copyright di proprietà di Yeasen Biotechnology. I simboli dei marchi indicano il paese di origine, non necessariamente la registrazione in tutte le regioni.
Alcune applicazioni potrebbero richiedere ulteriori diritti di proprietà intellettuale di terze parti.
Yeasen è un sostenitore della scienza etica, convinto che la nostra ricerca debba affrontare questioni critiche garantendo al contempo sicurezza e standard etici.


